Association of cortactin and mdm2 in solid Ameloblastoma and its malignant counterpart

NA Radi - Egyptian Dental Journal, 2019 - journals.ekb.eg
Ameloblastoma is characterized by heterogeneity regarding its pathogenetic development,
molecular abnormalities, and clinical course. Determining the molecular basis underlying …

[PDF][PDF] Транскрипционные особенности и метастатический потенциал клеток инвазивных структур рака молочной железы: магистерская диссертация по …

СЮ Золотарева - 2021 - vital.lib.tsu.ru
Объект исследования–больные раком молочной железы (n= 84; T1-4N0-3M0). Предмет
исследования–транскриптом клеток инвазивных структур рака молочной железы. Цель …

[HTML][HTML] Immunohistochemichal assessment of the CrkII proto-oncogene expression in common malignant salivary gland tumors and pleomorphic adenoma

M Askari, M Darabi, E Jahanzad… - Journal of dental …, 2015 - ncbi.nlm.nih.gov
Background and aims. Various morphologies are seen in different salivary gland tumorsor
within an individual tumor, and the lesions show divers biological behaviors. Experimental …

Diagnostic Performance of Cortactin in the Diagnosis of Oral Squamous Cell Carcinoma

L Wang, H Song, S Yang - 2020 - researchsquare.com
Background: Cortactin gene was up-regulated in various human cancers. However, the role
of cortactin in the diagnosis of oral squamous cell carcinoma (OSCC) remained unclear. The …

Intracellular Signaling Mechanisms of Resistance to EGFR-Targeting Agents

KM Quesnelle - 2012 - search.proquest.com
The epidermal growth factor receptor (EGFR) is widely expressed in head and neck
squamous cell carcinomas (HNSCC) and activates many growth and survival pathways …

Investigation of the biological function of arginine methyltransferase PRMT5 in human cancers

L Jin - 2020 - ora.ox.ac.uk
PRMT5 is a major type II arginine methyltransferase and plays a crucial role in
tumorigenesis. PRMT5 is overexpressed in multiple tumour cell lines, and a high level of …

[PDF][PDF] Evaluating Synthetic Actin Targeting Compounds for Use in a HER2 Targeted Cancer Therapeutic

S Nersesian - 2018 - qspace.library.queensu.ca
Abstract Human Epidermal Growth Factor Receptor-2 (HER2) is a driver and clinical target
in a subset of breast and ovarian cancers with high rates of metastasis. Metastatic cancer …

sdj-10030

DN Mohammad, BT Garib, HH Khudeir… - SDJ, 2017 - sites.google.com
Objectives: to assess the expression and pattern distribution of P-cadherin and cortactin in
OSCC, and to relate such expression to the histopathological grading. Materials and …

[PDF][PDF] Medicine and Surgery

G Marioni, E Zanoletti, A Mazzoni, A Gianatti… - 2017 - academia.edu
Purpose: Cortactin is a multidomain protein engaged in several cellular mechanisms
involving actin assembly and cytoskeletal arrangement. Cortactin overexpression in several …

Untersuchung der Eignung des iTRAQ-basierten, proteomanalytischen Quantifizierungsverfahrens zur Identifizierung zellulärer Mechanismen des Einflusses von …

V Richter - 2014 - ediss.sub.uni-hamburg.de
Das Ziel dieser Arbeit war es zu prüfen, ob mittels eines semiquantitativen,
proteomanalytischen Ansatzes unter Anwendung einer Markierungsstrategie mit der …